Trump’s Marijuana Mistake

The Justice Department announced Thursday that it was immediately reclassifying marijuana from a Schedule I drug, like heroin, to a Schedule III drug, like common painkillers, a move it said would allow further research into the drug’s effectiveness as a medicine. But there is already an extensive body of research showing marijuana causes far more harm than benefits to patients, and rescheduling will turbocharge investment in an industry that hurts the very Americans President Donald Trump swore to protect.

Trump’s Marijuana Mistake

TL;DR

  • The Justice Department reclassified marijuana from Schedule I to Schedule III.
  • This move, initiated under Biden and continued by Trump, is criticized for potentially increasing investment in the marijuana industry.
  • Research suggests marijuana use is linked to numerous harms, including increased hospitalizations, schizophrenia, heart attacks, and cognitive decline.
  • Medical benefits of marijuana are considered slim compared to its documented harms.
  • Rescheduling marijuana could provide tax breaks and banking privileges to the commercial marijuana industry.
  • The article argues that marijuana normalization has led to more addiction, social disorder, and public harm.
  • Voter support for marijuana legalization has fallen, especially among Republicans.